Jacqueline C Rendall
Overview
Explore the profile of Jacqueline C Rendall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Millar B, Alexander L, Bell J, Grieve E, McCabe C, Wright E, et al.
Ulster Med J
. 2024 Dec;
93(2):67-82.
PMID: 39669952
Background: In Northern Ireland, approximately 550 people with cystic fibrosis (PwCF) attend the regional paediatric and adult centres within the Belfast Health and Social Care Trust. This autosomal recessive chronic...
2.
Moore J, McCaughan J, Rendall J, Millar B
Br J Biomed Sci
. 2024 Jun;
81:12749.
PMID: 38895586
Within cystic fibrosis microbiology, there is often mismatch between the antibiotic susceptibility result of an isolated bacterial pathogen and the clinical outcome, when the patient is treated with the same...
3.
Millar B, Bell J, Rendall J, Moore J
Physiotherapy
. 2024 Jun;
124():101-105.
PMID: 38875837
Objectives: To estimate the carriage of Neisseira meningitidis (meningococci) in expectorated sputum from people with cystic fibrosis (CF) and to evaluate potential ramifications of such carriage for the health and...
4.
Millar B, Rendall J, Moore J
Infect Dis Health
. 2024 Apr;
29(4):185-195.
PMID: 38644104
Background: Respiratory infection is a major cause of disease severity in people with cystic fibrosis (PwCF). This project aimed to establish the CF community's opinion regarding cross infection (CI), nebuliser...
5.
Moore J, Rendall J, Millar B
Infect Dis Health
. 2023 May;
28(4):265-270.
PMID: 37258345
Background: Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a significant pathogen in people with cystic fibrosis (PwCF). There is a paucity of reports on MRSA infection dynamics within CF. It...
6.
Moore J, Rendall J, Millar B
Mycopathologia
. 2023 Apr;
188(5):699-704.
PMID: 37012557
Objective: Aspergillus fumigatus (A. fumigatus) has emerged as a significant pathogen in patients with cystic fibrosis (CF) and currently is within the top five isolated organisms reported in several international...
7.
Millar B, McCaughan J, Rendall J, Moore J
J Infect
. 2023 Feb;
86(6):626-628.
PMID: 36822406
No abstract available.
8.
Millar B, McCafferty M, McCann C, ONeill D, Rendall J, Moore J
Infect Dis Health
. 2023 Jan;
28(2):115-129.
PMID: 36641287
Background: The avoidance of cross-infection remains of critical importance to prevent the transmission of cystic fibrosis (CF)-related microbial pathogens to persons/people with cystic fibrosis (PwCF). To date, there has been...
9.
Moore J, McCaughan J, Rendall J, Millar B
Br J Biomed Sci
. 2022 Aug;
79:10468.
PMID: 35951661
There is a paucity of reports on non- (NAPs) in cystic fibrosis, hence this study wished 1). to examine the diversity/frequency of NAPs in an adult CF population, 2) to...
10.
ODoherty M, ONeill D, Rendall J, Moore J, Millar B
Respir Care
. 2022 Jul;
67(9):1161-1167.
PMID: 35882472
Background: Nebulized therapies form an important component of treatment in people with cystic fibrosis (CF). It is important for people with CF to continue to take their nebulized medications when...